bullish
Jinxin Fertility: Takeaways from Wuhan NDR and Yunnan Acquisition
241 Views21 Jun 2021 13:03
Jinxin Fertility announced the acquisition of 19.33% indirect economic interest in two Yunnan based hospitals in China and hosted an online NDR in its Wuhan Hospital last Saturday.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
- Jinxin Fertility 1H2021: A Clear Picture of the Long Term Potential06 Sep 2021
- Jinxin Fertility: Signs of Policy Tailwind and Valuation Dislocation29 Jul 2021
- Jinxin Fertility (锦欣生殖) Placement - A Familiar Name by Now and Don't Expect Extravagant Returns05 Jul 2021
- Jinxin Fertility: Takeaways from Wuhan NDR and Yunnan Acquisition21 Jun 2021
- China: 3rd Child Policy and 3 Beneficiaries01 Jun 2021
- Jinxin Fertility: Long Term IVF Story Intact Despite Potential Post Results De-Rating29 Mar 2021
x